John K. Buolamwini
- Molecular Biology top 5%
- Organic Chemistry top 2%
- Oncology top 5%
- Computational Theory and Mathematics top 2%
- Infectious Diseases top 5%
- Co-authors
- Shantaram KamathFrancis Ali‐OsmanJia-Xi MaoGamil R. AntounHaregewein AssefaShivaputra A. PatilRaymond F. SchinaziTino W. Sanchez
- Topics
- Adenosine and Purinergic Signaling (18 papers)Cancer-related Molecular Pathways (14 papers)HIV/AIDS drug development and treatment (13 papers)
- Cited by
- PhysiologyVirologyMolecular Biology
- Partner nations
- United StatesChinaCanada
In The Last Decade
John K. Buolamwini
75 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Molecular Biology 1.9k
- Organic Chemistry 755
- Oncology 728
- Computational Theory and Mathematics 286
- Infectious Diseases 280
Countries citing papers authored by John K. Buolamwini
This map shows the geographic impact of John K. Buolamwini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John K. Buolamwini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John K. Buolamwini more than expected).
Fields of papers citing papers by John K. Buolamwini
This network shows the impact of papers produced by John K. Buolamwini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John K. Buolamwini. The network helps show where John K. Buolamwini may publish in the future.
Co-authorship network of co-authors of John K. Buolamwini
This figure shows the co-authorship network connecting the top 25 collaborators of John K. Buolamwini. A scholar is included among the top collaborators of John K. Buolamwini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John K. Buolamwini. John K. Buolamwini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 21 | |
| 3 | 16 | |
| 4 | 81 | |
| 5 | 17 | |
| 6 | 92 | |
| 7 | 26 | |
| 8 | 100 | |
| 9 | 33 | |
| 10 | 29 | |
| 11 | 15 | |
| 12 | 45 | |
| 13 | 115 | |
| 14 | Novel anticancer agents : strategies for discovery and clinical testing | 7 |
| 15 | 96 | |
| 16 | 16 | |
| 17 | 1 | |
| 18 | 47 | |
| 19 | 21 | |
| 20 | 80 |
About John K. Buolamwini
John K. Buolamwini is a scholar working on Physiology, Oncology and Virology, having authored 75 papers that have together received 3.1k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (18 papers), Cancer-related Molecular Pathways (14 papers) and HIV/AIDS drug development and treatment (13 papers). The work is most often cited by research in Physiology (201 citations), Virology (147 citations) and Molecular Biology (1.9k citations). John K. Buolamwini has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Shantaram Kamath, Francis Ali‐Osman, Jia-Xi Mao, Gamil R. Antoun, Haregewein Assefa, Shivaputra A. Patil, Raymond F. Schinazi, Tino W. Sanchez, Nouri Neamati and Amol Gupte. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.